September 19, 2024
For decades, Kathy Steece-Collier, PhD, professor of translational neuroscience, has been researching ways to improve the quality of life for Parkinson’s patients. Her work has led to a new gene therapy that could reduce or eliminate symptoms. Evidence also suggests this therapy has potential to halt progression of the disease.